Related Experiment Video
Updated: Feb 13, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
Down-regulation of GADD45A enhances chemosensitivity in melanoma
Jia Liu1, Guoqiang Jiang1, Ping Mao2
1Department of Biotechnology, Dalian Medical University, Dalian, 116044, Liaoning, China.
Abstract:
Melanoma is a malignant skin cancer with considerable drug resistance. Increased expression of DNA repair genes have been reported in melanoma, and this contributes to chemotherapy resistance. GADD45A is involved in DNA repair, cell cycle arrest and apoptosis in response to physiologic or environmental stresses. In this study, we investigated the role of GADD45A in chemotherapy response. Firstly, the mRNA expression of profiled DNA repair genes in cisplatin-treated melanoma cells was detected by RT2 profilerTM PCR array. We found the expression of GADD45A upregulated in a dose- and time- dependent manner. In addition, suppression of GADD45A sensitized melanoma cells to cisplatin and enhanced cisplatin-induced DNA damage. Flow cytometry revealed that downregulating GADD45A released cells from cisplatin-induced G2/M arrest and increased apoptosis. By using a MEK inhibitor, GADD45A was shown to be regulated by MAPK-ERK pathway following cisplatin treatment. Thus, the induction of GADD45A might play important roles in chemotherapy response in human melanoma cancer and could serve as a novel molecular target for melanoma therapy.
Insights
Growth arrest and DNA-damage-inducible alpha (GADD45A) protein is upregulated in melanoma cells treated with chemotherapy. Suppressing GADD45A enhances chemotherapy effectiveness by increasing DNA damage and apoptosis, suggesting GADD45A as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Melanoma exhibits significant drug resistance, often linked to increased DNA repair gene expression.
- Growth arrest and DNA-damage-inducible alpha (GADD45A) is a key gene involved in DNA repair, cell cycle arrest, and apoptosis.
- Understanding GADD45A's role is crucial for improving melanoma chemotherapy response.
Purpose of the Study:
- To investigate the role of GADD45A in the response of melanoma cells to chemotherapy.
- To determine if GADD45A expression is altered by cisplatin treatment.
- To explore the therapeutic potential of targeting GADD45A in melanoma.
Main Methods:
- RT2 profiler PCR array to analyze DNA repair gene expression in cisplatin-treated melanoma cells.
- Cell viability assays and flow cytometry to assess the impact of GADD45A suppression on cisplatin sensitivity, DNA damage, cell cycle arrest, and apoptosis.
- MEK inhibitor treatment to investigate the involvement of the MAPK-ERK pathway.
Main Results:
- GADD45A mRNA expression was upregulated in a dose- and time-dependent manner following cisplatin treatment.
- Suppression of GADD45A sensitized melanoma cells to cisplatin, enhanced DNA damage, and increased apoptosis.
- Downregulating GADD45A released cells from cisplatin-induced G2/M arrest.
- GADD45A induction was found to be regulated by the MAPK-ERK pathway.
Conclusions:
- GADD45A plays a significant role in the chemotherapy response of human melanoma.
- Targeting GADD45A may represent a novel therapeutic strategy to overcome drug resistance in melanoma.
- Further research into the GADD45A-MAPK-ERK pathway could yield new treatment approaches for melanoma.
Related Concept Videos
GTPases and their Regulation
Large G-proteins,...
Master Transcription Regulators
Epigenetic Regulation
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Self-Evaluation: Self-Enhancement and Self-Verification
Negative Regulator Molecules

